CA3071937A1 - Methode et systeme permettant d'utiliser une energie en vue de traiter un tissu biologique - Google Patents
Methode et systeme permettant d'utiliser une energie en vue de traiter un tissu biologique Download PDFInfo
- Publication number
- CA3071937A1 CA3071937A1 CA3071937A CA3071937A CA3071937A1 CA 3071937 A1 CA3071937 A1 CA 3071937A1 CA 3071937 A CA3071937 A CA 3071937A CA 3071937 A CA3071937 A CA 3071937A CA 3071937 A1 CA3071937 A1 CA 3071937A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- treatment
- para
- time
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- 230000008569 process Effects 0.000 title claims abstract description 36
- 238000011282 treatment Methods 0.000 claims abstract description 307
- 230000005855 radiation Effects 0.000 claims abstract description 134
- 230000002207 retinal effect Effects 0.000 claims abstract description 71
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 29
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 197
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 197
- 230000004913 activation Effects 0.000 claims description 50
- 230000000451 tissue damage Effects 0.000 claims description 14
- 231100000827 tissue damage Toxicity 0.000 claims description 14
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 description 186
- 230000006378 damage Effects 0.000 description 56
- 210000001525 retina Anatomy 0.000 description 46
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 44
- 238000001994 activation Methods 0.000 description 41
- 238000010521 absorption reaction Methods 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 37
- 230000000694 effects Effects 0.000 description 30
- 230000003287 optical effect Effects 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 22
- 230000006870 function Effects 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 20
- 101100506686 Arabidopsis thaliana HSFA1B gene Proteins 0.000 description 18
- 101150017616 Hsf3 gene Proteins 0.000 description 18
- 101100071480 Oryza sativa subsp. japonica HSFA1 gene Proteins 0.000 description 18
- 230000000254 damaging effect Effects 0.000 description 18
- 230000007246 mechanism Effects 0.000 description 18
- 230000006399 behavior Effects 0.000 description 15
- 230000008901 benefit Effects 0.000 description 15
- 241000894007 species Species 0.000 description 15
- 101100421857 Caenorhabditis elegans sod-2 gene Proteins 0.000 description 14
- 230000000649 photocoagulation Effects 0.000 description 14
- 230000007423 decrease Effects 0.000 description 12
- 230000001413 cellular effect Effects 0.000 description 11
- 108020004999 messenger RNA Proteins 0.000 description 11
- 230000006872 improvement Effects 0.000 description 10
- 230000008439 repair process Effects 0.000 description 10
- 230000035939 shock Effects 0.000 description 10
- 238000009792 diffusion process Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 6
- 208000017442 Retinal disease Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- 201000011190 diabetic macular edema Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 230000035515 penetration Effects 0.000 description 6
- 230000005451 protein repair Effects 0.000 description 6
- 206010012689 Diabetic retinopathy Diseases 0.000 description 5
- 230000001427 coherent effect Effects 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 238000013021 overheating Methods 0.000 description 5
- 239000000790 retinal pigment Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 230000004393 visual impairment Effects 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000005779 cell damage Effects 0.000 description 4
- 208000037887 cell injury Diseases 0.000 description 4
- 230000001066 destructive effect Effects 0.000 description 4
- 230000005670 electromagnetic radiation Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000000750 progressive effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 2
- 206010057430 Retinal injury Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000004637 cellular stress Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000036575 thermal burns Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000024304 Choroidal Effusions Diseases 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010008783 Choroidal detachment Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000014824 Crystallins Human genes 0.000 description 1
- 108010064003 Crystallins Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 101000990176 Escherichia coli (strain K12) Protein/nucleic acid deglycase 1 Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038895 Retinal scar Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 208000036038 Subretinal fibrosis Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000034698 Vitreous haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000013533 micropulse laser treatment Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 230000004286 retinal pathology Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Cultivation Of Seaweed (AREA)
Abstract
L'invention concerne une méthode de traitement thermique d'un tissu biologique, comprenant la génération d'un rayonnement de traitement présentant une longueur d'onde et une puissance moyenne prédéterminées. Le rayonnement de traitement est appliqué à un tissu biologique, tel qu'un tissu rétinien, de manière à former au moins un point de traitement sur le tissu biologique et à stimuler thermiquement le tissu biologique suffisamment pour créer un effet thérapeutique sans détruire le tissu.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/813,645 | 2017-11-15 | ||
| US15/813,645 US10357398B2 (en) | 2016-03-21 | 2017-11-15 | System and process for treatment of myopia |
| US15/918,487 | 2018-03-12 | ||
| US15/918,487 US10874873B2 (en) | 2012-05-25 | 2018-03-12 | Process utilizing pulsed energy to heat treat biological tissue |
| US16/038,561 | 2018-07-18 | ||
| US16/038,561 US10596389B2 (en) | 2012-05-25 | 2018-07-18 | Process and system for utilizing energy to treat biological tissue |
| PCT/US2018/042833 WO2019099068A1 (fr) | 2017-11-15 | 2018-07-19 | Méthode et système permettant d'utiliser une énergie en vue de traiter un tissu biologique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3071937A1 true CA3071937A1 (fr) | 2019-05-23 |
Family
ID=66538738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3071937A Pending CA3071937A1 (fr) | 2017-11-15 | 2018-07-19 | Methode et systeme permettant d'utiliser une energie en vue de traiter un tissu biologique |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3703815A1 (fr) |
| JP (1) | JP7130271B2 (fr) |
| CN (1) | CN111343936B (fr) |
| AU (1) | AU2018369022B2 (fr) |
| BR (1) | BR112020009238A2 (fr) |
| CA (1) | CA3071937A1 (fr) |
| WO (1) | WO2019099068A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| CN113286630B (zh) | 2019-04-11 | 2024-08-02 | 比特乐医疗方案股份有限公司 | 通过射频和磁能对生物结构进行美容治疗的方法和装置 |
| CN110237432A (zh) * | 2019-06-06 | 2019-09-17 | 中山大学中山眼科中心 | 一种增加眼底血流和代谢率的方法 |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| EP4415812A1 (fr) | 2021-10-13 | 2024-08-21 | BTL Medical Solutions a.s. | Dispositifs de traitement esthétique de structures biologiques par énergie radiofréquence et magnétique |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5951596A (en) * | 1991-07-01 | 1999-09-14 | Laser Biotherapy Inc | Biological tissue stimulation by optical energy |
| JP3977017B2 (ja) * | 2001-02-01 | 2007-09-19 | 株式会社ニデック | レーザ治療装置 |
| JP3613634B2 (ja) * | 2001-11-06 | 2005-01-26 | 得一郎 長谷川 | 視力矯正装置 |
| KR20080031474A (ko) | 2005-07-27 | 2008-04-08 | 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. | 안구 질환의 치료를 위한 열충격의 사용 |
| WO2008013985A2 (fr) * | 2006-07-27 | 2008-01-31 | University Of Florida | Utilisation d'activateurs de choc thermique pour la régénération tissulaire |
| US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| JP4996237B2 (ja) * | 2006-12-26 | 2012-08-08 | 株式会社ニデック | 眼科用レーザ治療装置 |
| CA2712951A1 (fr) | 2008-01-18 | 2009-07-23 | The General Hospital Corporation | Photostimulation selective destinee a induire une proliferation cellulaire |
| EP2739357B1 (fr) * | 2011-07-10 | 2023-09-06 | Guided Therapy Systems, L.L.C. | Système pour améliorer l'aspect extérieur de la peau en utilisant les ultrasons comme source d'énergie |
| US10219947B2 (en) | 2012-05-25 | 2019-03-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| US10953241B2 (en) * | 2012-05-25 | 2021-03-23 | Ojai Retinal Technology, Llc | Process for providing protective therapy for biological tissues or fluids |
| US10278863B2 (en) * | 2016-03-21 | 2019-05-07 | Ojai Retinal Technology, Llc | System and process for treatment of myopia |
| US10531908B2 (en) * | 2012-05-25 | 2020-01-14 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| US9381115B2 (en) * | 2012-05-25 | 2016-07-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| SG11201705677WA (en) * | 2015-01-28 | 2017-08-30 | Ojai Retinal Tech Llc | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
| CA2972438C (fr) * | 2015-01-28 | 2020-09-15 | Ojai Retinal Technology, Llc | Traitement prophylactique par laser a micro-impulsions infraliminaire pour maladies evolutives chroniques de la retine |
-
2018
- 2018-07-19 JP JP2020507031A patent/JP7130271B2/ja active Active
- 2018-07-19 EP EP18877518.3A patent/EP3703815A1/fr active Pending
- 2018-07-19 CA CA3071937A patent/CA3071937A1/fr active Pending
- 2018-07-19 CN CN201880073796.XA patent/CN111343936B/zh active Active
- 2018-07-19 WO PCT/US2018/042833 patent/WO2019099068A1/fr active Application Filing
- 2018-07-19 AU AU2018369022A patent/AU2018369022B2/en active Active
- 2018-07-19 BR BR112020009238-0A patent/BR112020009238A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021502834A (ja) | 2021-02-04 |
| WO2019099068A1 (fr) | 2019-05-23 |
| JP7130271B2 (ja) | 2022-09-05 |
| CN111343936B (zh) | 2024-03-22 |
| AU2018369022A1 (en) | 2020-03-12 |
| BR112020009238A2 (pt) | 2020-10-20 |
| CN111343936A (zh) | 2020-06-26 |
| EP3703815A4 (fr) | 2020-09-09 |
| EP3703815A1 (fr) | 2020-09-09 |
| AU2018369022B2 (en) | 2023-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018369022B2 (en) | Process and system for utilizing energy to treat biological tissue | |
| US10709607B2 (en) | System and process for treatment of myopia | |
| US10285859B2 (en) | System for performing retina photostimulation | |
| AU2021215167B2 (en) | System and process for retina phototherapy | |
| AU2017412681B2 (en) | System and process for treatment of myopia | |
| US10596389B2 (en) | Process and system for utilizing energy to treat biological tissue | |
| EP4196032A1 (fr) | Système et procédé d'irradiation rétinienne pour améliorer la fonction et la santé oculaires dans l'oeil normalement vieillissant | |
| US20210339039A1 (en) | Retinal phototherapy system and method having fixed parameters | |
| EP4329874A1 (fr) | Système de photothérapie rétinienne et procédé à paramètres fixes | |
| US20210339044A1 (en) | Retinal irradiation system and method to improve ocular function and health in the normally aging eye | |
| EP4329690A1 (fr) | Système et procédé d'irradiation rétinienne pour améliorer la fonction et la santé oculaires dans un oeil vieillissant normalement | |
| CA3051444A1 (fr) | Methode utilisant une energie pulsee pour traiter thermiquement un tissu biologique | |
| CN117479907A (zh) | 改善正常衰老眼睛的眼功能和健康的视网膜照射系统和方法 | |
| CA3091103A1 (fr) | Systeme et procede d'utilisation d'energie pour traiter un tissu biologique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |
|
| EEER | Examination request |
Effective date: 20220909 |